We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$204B
AUM Growth
+$40.7B
Cap. Flow
+$14.4B
Cap. Flow %
7.02%
Top 10 Hldgs %
15.11%
Holding
4,579
New
569
Increased
2,381
Reduced
1,060
Closed
261

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$845M
2
TME icon
Tencent Music
TME
+$643M
3
BIDU icon
Baidu
BIDU
+$528M
4
TSLA icon
Tesla
TSLA
+$476M
5
AMZN icon
Amazon
AMZN
+$391M

Sector Composition

Rank Sector Weight
1 Technology 13.51%
2 Consumer Discretionary 9.39%
3 Healthcare 9.23%
4 Communication Services 7.28%
5 Financials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HQY icon
326
HealthEquity
HQY
$8.72B
$128M 0.06%
1,834,174
+1,105,119
+152% +$68.7M
ADI icon
327
Analog Devices
ADI
$176B
$127M 0.06%
860,655
+24,883
+3% +$3.3M
HD icon
328
CALL
Home Depot
HD
$339B
$127M 0.06%
477,500
+33,900
+8% +$9.32M
ALL icon
329
Allstate
ALL
$67.6B
$127M 0.06%
1,152,833
-225,864
-16% -$22.2M
BA icon
330
CALL
Boeing
BA
$185B
$127M 0.06%
591,400
+229,100
+63% +$44M
AXNX
331
DELISTED
Axonics, Inc. Common Stock
AXNX
$126M 0.06%
2,530,981
+568,745
+29% +$26.7M
PAYX icon
332
Paychex
PAYX
$41.9B
$126M 0.06%
1,353,350
-80,227
-6% -$7.12M
DAL icon
333
PUT
Delta Air Lines
DAL
$60.2B
$125M 0.06%
3,109,700
+1,319,300
+74% +$48M
REGN icon
334
Regeneron Pharmaceuticals
REGN
$78.2B
$125M 0.06%
257,864
+674
+0.3% +$364K
AON icon
335
Aon
AON
$75.9B
$124M 0.06%
588,774
+83,737
+17% +$17.1M
ROKU icon
336
PUT
Roku
ROKU
$21.6B
$124M 0.06%
373,200
+38,100
+11% +$9.99M
PANW icon
337
Palo Alto Networks
PANW
$283B
$124M 0.06%
2,089,326
+50,256
+2% +$2.35M
CB icon
338
Chubb
CB
$134B
$123M 0.06%
801,233
+11,299
+1% +$1.58M
EFA icon
339
iShares MSCI EAFE ETF
EFA
$78.4B
$123M 0.06%
1,689,091
+481,476
+40% +$32.9M
FSLY icon
340
PUT
Fastly Inc
FSLY
$3.6B
$123M 0.06%
1,408,400
+650,900
+86% +$57.4M
AYX
341
DELISTED
Alteryx Inc
AYX
$123M 0.06%
1,009,569
+170,295
+20% +$21.5M
ZS icon
342
Zscaler
ZS
$25B
$123M 0.06%
615,613
+80,587
+15% +$12.8M
EFX icon
343
Equifax
EFX
$20.5B
$123M 0.06%
635,675
+57,810
+10% +$9.72M
DD icon
344
DuPont de Nemours
DD
$19.1B
$122M 0.06%
1,362,832
+329,845
+32% +$25.9M
CRSP icon
345
CRISPR Therapeutics
CRSP
$4.88B
$121M 0.06%
793,444
+91,158
+13% +$10.8M
TER icon
346
Teradyne
TER
$57.3B
$121M 0.06%
1,012,291
+656,372
+184% +$67.1M
EW icon
347
Edwards Lifesciences
EW
$51.1B
$120M 0.06%
1,316,403
+159,010
+14% +$13.2M
MRNA icon
348
PUT
Moderna
MRNA
$21.9B
$120M 0.06%
1,147,500
-9,100
-0.8% -$921K
ONEM
349
DELISTED
1Life Healthcare
ONEM
$120M 0.06%
2,742,144
+1,019,623
+59% +$34.8M
TWST icon
350
Twist Bioscience
TWST
$6.29B
$120M 0.06%
846,581
+800,661
+1,744% +$88.8M

Similar funds

Credit Suisse's Q4 2020 Portfolio in Review

As of Q4 2020, Credit Suisse held 4,579 positions worth $204B, up 25% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $14.4B of net new capital in Q4 2020, opening 569 new positions and adding to 2,381 existing holdings. Its largest new stake was Palantir: 6,341,206 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $546M trimmed.

  • Credit Suisse's largest Q4 2020 buy was Palantir: 6,341,206 shares worth $149M.
  • Credit Suisse added most to Alibaba in Q4 2020, an estimated $845M increase.
  • Credit Suisse's biggest Q4 2020 reduction was UnitedHealth, cutting an estimated $546M.
  • Credit Suisse fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $260M.
  • Credit Suisse's ten largest holdings make up 15% of its $204B portfolio in Q4 2020.
  • Credit Suisse opened 569 new positions and closed 261 in Q4 2020.
  • Credit Suisse's portfolio value rose 25% quarter-over-quarter to $204B.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.